Clinical Trial Update: Pharmacology of Cognition in Schizotypal Personality Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating pharmacology of cognition in schizotypal personality disorder has been terminated; sponsor is Icahn School of Medicine at Moun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Personality Disorders
• Schizotypal Personality Disorder

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Schizotypal Personality Disorder, Personality Disorders | Phase 4 | Status: TERMINATED